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influenced by basic ischemic factors and may, under pathophysiological con-
ditions, be of importance in regulating Ca2+-entry and stimulation-secretion
coupling by modulating membrane potential.
Endothelin-1 (ET-l) is an endothelial-derived coronary vasoconstrictor pep-
tide which mediates its actions through the Endothelin-A and the Endothelin-
B receptors. The current study was designed to test the hypothesis that
at low-dose ET-l to mimic pathophysiologic concentrations, ET-1 mediates
coronary vasoconstriction through the ET-A receptor. Therefore, ET-1 , (Group
1, n = 5). Sarafotoxin-a specific ET-B receptor agonist (Group 2, n = 5)-
each at 2 ng/kg/min were infused into the left circumflex coronary artery in
the anesthetized dog. In Group 3 (n = 5) the same dose of ET-1 was infused
with 4 j!glkg/min of the specific ET-A receptor antagonist FR 139317. No dif-
ference in hemodynamics and coronary blood flow (CBF), coronary vascular
resistance (CVR), and coronary artery diameter(CADI were observed at base-
line between the groups, and no alterations in systemic hemodynamics and
plasma ET concentrations were observed during the protocol. CBF, CVR, and
CAD were determined at baseline and during infusions and were calculated
as % change (LI.) from baseline.
p Value
071
030
0.34
00001
0,0001
0.018
0,22
0,93
0,69
control
16 ± 7*
77%
21%*
2%
29%
4%
3.5*
HPCD In = 29)
26 (90%)
27 (93%)
134± 18
274 ± 61
2±6
15.8 ± 3,3
1.1 ± 0.4
79 ± 2,2
7.7 ± 1,1
MC In ~ 25)
24 (96%)
20 (80%)
129 ± 9
163 ± 17
16 ± 5
18.1 ± 3.6
1,2 ± 0.4
7.9 ± 16
7,6± 1.0
single collagen plug
3±3
87%
8%
5%
20%
5%
8.3
Advantages of Sealing Arterial Puncture Sites
After PTCA with a Single Collagen Plug: A
Randomized, Prospective Trial
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Only little data exist comparing collagen plugging of arterial puncture sites
at identical conditions with conventional sheath pulling. Furthermore it has
not been investigated whether one single plug is also effective after PTCA.
Therefore we randomized 150 pats to either one single collagen plug or con-
ventional sheath (BF) pulling, Both groups did not differ in age, gender, BSA,
BP or APTT.
Results:
There was 1 unsuccessful hemostasis due to hematoma in the MC and 2
in the HPCD group. There was one rebleeding episode requiring prolonged
manual pressure in the HPCD group, All stent patients were treated with-
out subsequent anticoagulation. The device anchor in the vessel was small
enough that it did not reduce the vessel diameter by ultrasound. This re-
sult was confirmed also at 2 month ultrasound follow up. Conclusions. (1)
The HPCD provides rapid hemostasis despite a high ACT, (2) HPCD enables
prompt sheath removal despite effective anticoagulation and also reduces
the effort of manual compression. (3) HPCD use allows for a reduction in
mobilization time and short hospital stay,
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system with an intraarterial anchor, To assess its efficacy, 56 patients were
randomized after BF percutaneous transcatheter interventions to either man-
ual compression (MC) (25 patients) or HPCD (29 patients). There was no sig-
nificant difference in the base line characteristics of age, gender, diabetes
and hypertension between the two groups. Successful hemostasis was de-
fined as the achievement of hemostasis without femoral hematoma, blood
transfusion or vascular repair. Type of procedures, systolic blood pressure
(BP), activating clotting time (ACT). total hemostasis duration, time to mo-
bilization and hospital stay after the removal of the sheath were compared.
Ultrasound vessel measurements made at the puncture site after the proce-
dure and 2 months follow up (FlU) were also compared.
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Role of Endogenous Adenosine in Coronary
Pressure-Flow Relationship In Dogs
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There have been conflicting evidence for the role of adenosine in coronary
pressure flow relationship; although adenosine release increases when coro-
nary perfusion pressure (CPP) is reduced, adenosine deaminase does not
affect changes in coronary blood flow (CBF). To examine the role of endoge-
nous adenosine in coronary pressure flow relationship, responses of CBF
were observed during a stepwise reduction of CPP by 10 mmHg with and
without B-phenyltheophylline (BPT). In 32 dogs, the left anterior descend-
ing coronary artery was perfused from the carotid artery, where CBF was
measured. According to the reduction of CPP, adenosine concentration de-
tected in coronary venous blood was increased (CPP ~ 100 mmHg:7 ± 2,
BO mmHg:25 ± 3, 70 mmHg:53 ± 5, 40 mmHg:165 ± 11 pmollml), Admin-
istration of BPT reduced CBF by B ± 3% at CPP = 100 - 70 mmHg, and by
34 ± 7% at CPP = 60 - 40 mmHg. When CPP was altered between 100 and
70 mmHg, BPT markedly reduced (p < 0,001) fractional shortening (FS) and
lactate extraction ratio (LER) (FS:9,B ± 1.2 vs. 23.6 ± 1.2%, LER:-6,5 ± 1,9
vs. 26.7 ± 1.9% at CPP = 70 mmHg). Interestingly, BPT markedly reduced
End/Epi flow ratio by 35 ± 4% at CPP = 70 mmHg. Thus we conclude that
when CPP is reduced, endogenous adenosine favors endocardial myocardial
flow and preserves myocardial contractile and metabolic function.
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The hemostatic puncture device IHPCD Kensey-Nash Co,) is a collagen plug
Data are mean ± SEM, *p < 0.01 vs, Group 2 and Group 3, This study
demonstrates in vivo that: ET-l at pathophysiologic concentrations predom-
inantly induces coronary vasoconstriction via the ET-A receptors at the level
of the resistance vessels,
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A Randomized Study of the 8 French Hemostatic
Puncture Closure Device vs Manual Compression
After Coronary Interventions
*p < 0,05
Restenosis at stented sites has been attributed to neointimal proliferation.
Stent collapse from external compression may also contribute to resteno-
sis (Resten). We performed PTA and stenting in 6 hemodialysis conduits in
five patients. Four subclavian and two brachiocephalic vein stenoses were
initially treated with PTA and Palmaz stents, All sites developed early resteno-
sis (mean time ~ 3,3 ± 2 months). Whereas angiography suggested a clas-
sic proliferative mechanism of restenosis, intravascular ultrasound (IVUS)
demonstrated eccentric stent collapse: stent configuration was ovoid or slit-
like, rather than circular, and struts were not apposed to the vessel wall,
but instead were protruding into the lumen directly abutting the IVUS probe.
Neointimal proliferation was absent in all cases, Redilation was performed in
all cases, with additional stents placed in the 4 subclavian veins. All 6 vessels
Conclusions: Collagen plugging of arterial puncture sites after PTCA is as
effective as conventional sheath pulling and significantly reduces time to
hemostasis. Patient comfort is markedly increased. Since one single plug
is very effective, costs may be cut in half.
Restenosis of Stented Dialysis Conduits Caused
by Stent Collapse, not Neointimal Proliferation
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